ACRUX LIMITED (ACR)
Latest AI Signal: SELL
Status: NEW
Days Old: 2
Confidence: 75.00%
Date: 19-05-2026
Price: $0.010
Last Price: $0.010
Post-Signal Low Price: $0.010
Latest ACRUX LIMITED(ACR) News
Chart available once enough post-signal price data is available.
Sell Confidence High
AI Confidence - 75.00 % model confidence
Business Overview
Acrux Limited is an Australian specialty pharmaceutical company focused on the development and commercialization of transdermal drug delivery systems. It operates primarily in niche therapeutic areas with a focus on innovative drug formulations, targeting both domestic and international markets. The company holds a modest market position with limited scale and faces significant competition from larger pharmaceutical firms.
Financial Analysis
| Cash Flow | Weak |
| Debt | Moderate |
| Profitability | Weak |
| Revenue Trend | Downtrend |
Technical Analysis
| Trend | Bearish |
| Momentum | Weak |
| RSI Signal | Oversold |
| Support Level | $ 0.0095 |
| Resistance Level | $ 0.0120 |
Valuation
Valuation - UndervaluedThe stock price appears depressed relative to book value and potential future cash flows, but valuation is impacted by weak fundamentals and uncertain growth prospects.
Catalysts
• Potential licensing deals or partnerships to expand product portfolio.• Successful clinical trial outcomes or regulatory approvals.
• Strategic restructuring or capital raising to improve financial position.
Recommendation
Action - SellTimeframe - Short Term
Given Acrux's weak financial performance, bearish technical signals, and ongoing operational risks, the stock is likely to underperform in the near term. Investors should avoid exposure until clear signs of turnaround or positive catalysts emerge.